Case ReportJournal of Pharmacology and PharmacotherapeuticsVol. 7 | Issue 2 | 2016 | pp. 99–101Open access
An unusual case of glipizide-induced proximal myopathy
- 1*,
- 2,
- 1,
- 3
- 1 Nalmuri Block Primary Health Centre, South 24 Parganas, India.
- 2 Department of Pharmacology, Swamy Vivekanandha College of Pharmacy, Namakkal, Tamil Nadu, India.
- 3 Department of Clinical and Experimental Pharmacology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Saibal Das
Nalmuri Block Primary Health Centre, South 24 Parganas, India.
Copyright: © 2016 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2016
- Received:
- Apr 3, 2015
- Accepted:
- Aug 2, 2015
How to cite
Das, S., Ramasamy, A., De, S., & Mondal, S. (2016). An unusual case of glipizide-induced proximal myopathy. Journal of Pharmacology and Pharmacotherapeutics, 7(2), 99–101. https://doi.org/10.4103/0976-500X.184775
Abstract
This case report outlines a very rare case of glipizide‑induced severe proximal myopathy in a 61‑year‑old diabetic man. After taking 10 mg glipizide for 5 months, diabetes was well controlled but the patient presented with progressive proximal muscle weakness in all the four limbs. Clinical examination and relevant investigations suggested it to be a case of proximal myopathy and might be drug induced. De‑challenge was done and was treated resulting in reversal of the diseased state. After 3 more months, controlled re‑challenge was done and there was recurrence of proximal muscle weakness. There were no evidences of any other possible metabolic, infective, organic or other pathologic causes giving rise to that condition and Naranjo adverse drug reaction probability scale suggested that it was “probable” that glipizide was responsible for the development of myopathy in this patient.
Keywords
Subject
Article metadata
| Title | An unusual case of glipizide-induced proximal myopathy |
|---|---|
| Authors | Saibal Das; Anand Ramasamy; Soumyadip De; Somnath Mondal |
| Affiliations | Nalmuri Block Primary Health Centre, South 24 Parganas, India.; Department of Pharmacology, Swamy Vivekanandha College of Pharmacy, Namakkal, Tamil Nadu, India.; Department of Clinical and Experimental Pharmacology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India. |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 7, Issue 2 (2016) |
Also in this issue
- Expedited drug review process: Fast, but flawedpp. 57–58
- L-asparaginase in the treatment of patients with acute lymphoblastic leukemiapp. 62–71
- Factors influencing adherence to anti‑craving medications and drinking outcomes in patients with alcohol dependence: A hospital‑based studypp. 72–79
- Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patientspp. 80–86
- Is the peripheral arterial disease in low risk type 2 diabetic patients influenced by body mass index, lipidemic control, and statins?pp. 87–92
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026